Back

Infection management in the extravascular implantable cardioverter defibrillator: experience from the EV ICD Pivotal study

30 August 2024 (08:51 - 09:03)
Organised by: Logo
Congress Presentation Part of: Leadless vs. transvenous devices: efficacy and safety Device Complications and Lead Extraction ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Nicolas Clementy

Clinic du Millenaire, Montpellier (France)

4 More presentations in this session

Presentation thumbnail
Real-world evidence of implanting leadless pacemakers after transcatheter aortic valve implantation procedures
Doctor S. Zweibel (Hartford, US)
Abstract Slides Video
Presentation thumbnail
Comparative safety outcomes of leadless versus transvenous cardiac pacemaker: a systematic review and meta-analysis
Doctor M. Ohn (London, GB)
Abstract Slides Video
Presentation thumbnail
Eight year Follow-Up Data on a Leadless Pacing System Real life experience in comparison to data of the prospective trial
Doctor S. Winter (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Periprocedural complications during transvenous lead extraction. Lessons learned from the GermAn Laser Lead Extraction RegistrY (GALLERY)
Doctor D. Chung (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Leadless vs. transvenous devices: efficacy and safety
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 08:51 CET
You may be interested in
thumbnail
Congress Presentation
EV-ICD performance over time
thumbnail
Congress Presentation
Consistent ATP, defibrillation, and safety performance of the extravascular ICD: final results from the global EV-ICD Pivotal Study
thumbnail
Congress Session
Leadless vs. transvenous devices: efficacy and safety

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources